The Southwest Autism Research and Resource Center is recruiting young participants for a sleep study investigating a new version of the drug Circadin, according to KTAR News report.

“We’re involved in a new trial that’s investigating a new version of a medication that helps children fall asleep and stay asleep,” said Chris Smith, director of research at SARRC.

Smith said the study involves the drug Circadin, which is a timed-release variation of melatonin.

View the full story at